SOPHARMA AD: Current report 115 tender offer - Unipharm AD

opublikowano: 2016-12-15 14:41

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załącznikĂłw:
Current_report_115_tender_offer_-_Unipharm_AD.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 115 / 2016
Date of issue: 2016-12-15
Short name of the issuer
SOPHARMA AD
Subject
Current report 115 tender offer - Unipharm AD
Official market - legal basis
art. 17. 1 MAR.
Unofficial market - legal basis
Contents of the report:
Sopharma AD (the “Company”) hereby notifies that on 14 December 2016 Sopharma AD filed with the Financial Supervision Commission a tender offering for the shares of all other shareholders in Unipharm AD.

Sopharma AD as a offeree states that it does not own 1 342 234 shares, representing 22.37% from the total number of sahres with ISIN BG1100154076 and from the votes in the general meeting of Unipharm AD and files the tender offering to the remaining sahreholders owning ordinary shares of Unipharma AD for the purchase of those shares.
Annexes
File Description
Current report 115 tender offer - Unipharm AD.docCurrent report 115 tender offer - Unipharm AD.doc Current report 115 tender offer - Unipharm AD

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2016-12-15 Ognian Donev Executive director